GBK glossarySearch the glossaries created from glossary-building KudoZ (GBK) questions. | To see the desired glossary, please select the language and then the field of expertise. |
Home - English
- Search
- Term
- disease-modifying anti-rheumatic drug (DMARD)
- Additional fields of expertise
- Definition(s)
- Disease-modifying antirheumatic drugs (DMARDs) are a class of drugs indicated for the treatment of inflammatory arthritides including rheumatoid arthritis (RA), psoriatic arthritis (PsA), and ankylosing spondylitis (AS). They can also be used to in the treatment of other disorders including connective tissue disease such as systemic sclerosis (SSc), systemic lupus erythematosus (SLE), and Sjogren syndrome (SS), as well as in treatment of inflammatory myositis, vasculitis, uveitis, inflammatory bowel disease, and some types of cancers. National Center for Biotechnology Info.
- Example sentence(s)
- Hydroxychloroquine has been available since 1955 as an antimalarial drug. I have at least 6 patients at the pharmacy who have used hydroxychloroquine to manage their rheumatoid arthritis, lupus, and Crohn disease. If you were sitting in my pharmacology class, I’d tell you that it is an antimalarial used as a disease-modifying antirheumatic drug (DMARD). I would tell you it is a cheap drug with good efficacy for some and also that it is 1 of 2 DMARDs that are safe to use in patients with liver failure. You would also learn that it may cause deposition of the drug in the melanin layer of the cones in the retina, underscoring the need for annual eye exams. - MJH Life Sciences
by - DMARDs Not Linked to Poor Outcomes in SARS-CoV-2 RA Patients - Rheumatology Network
by - The analysis of performance measures for rheumatoid arthritis (RA) care have allowed to identify gaps in care that include suboptimal use of disease-modifying anti-rheumatic drugs (DMARDs), according to a study published in Arthritis Care & Research. - Rheumatology Advisor
by Compare [close] - Russian
- Search
- Term
- болезнь-модифицирующий антиревматический препарат (БМАРП)
- Additional fields of expertise
- Definition(s)
- Болезнь-модифицирующие антиревматические препараты (сокр. БМАРП; синоним: базисные противоревматические препараты) — это большая и неоднородная группа лекарственных препаратов, объединённых общей способностью не только снимать симптомы и неспецифически уменьшать воспаление суставов у больных ревматоидным артритом, но и модифицировать, смягчать или тормозить прогрессирование самого заболевания, деструкцию кости и другие специфические поражения. Wikipedia - by Tetiana Tkachenko
- Example sentence(s)
- БПВП (синонимы: базисные препараты, болезнь-модифицирующие антиревматические препараты, медленно действующие препараты) являются главным компонентом лечения ревматоидного артрита и при отсутствии противопоказаний должны быть назначены каждому пациенту с этим диагнозом [9]. - Лечащий Врач
by Tetiana Tkachenko - К базисным препаратам лечения РА относят болезнь-модифицирующие антиревматические препараты, отличительной особенностью которых при сравнении с НПВП и ГК является их способность уменьшать и/или предотвращать повреждение суставов, сохранять их структуру и функцию. - Крымский терапевтиче�
by Tetiana Tkachenko - Болезнь-модифицирующие антиревматические препараты (БМАРП) играют основную роль в лечении РА, потому что не только облегчают симптомы, но, прежде всего, тормозят разрушение суставов, позволяя сохранить физическую полноценность и нормальное функционирование в повседневной жизни. - Empendium - портал для врач
by Tetiana Tkachenko - Related KudoZ question
Compare [close] - Dutch
- Search
- Term
- Ziekteverloop beïnvloedende geneesmiddelen tegen reuma
- Additional fields of expertise
- Definition(s)
- Disease-modifying antirheumatic drugs ("ziekteverloop beïnvloedende geneesmiddelen tegen reuma") of DMARD's vormen een groep geneesmiddelen die de activiteit van ontstekingen in de gewrichten vermindert. De middelen worden gegeven met als doelstelling het zo veel mogelijk voorkomen van gewrichtsbeschadiging zoals die bij reumatoïde artritis veel voorkomen. nl.wikipedia.org - by Stieneke Hulshof
- Example sentence(s)
- Sulfasalazine is een middel dat ontstekingen in de gewrichten onderdrukt bij een aantal vormen van reuma. Het is sinds 1944 op de markt. Dit medicijn behoort tot de zogenaamde DMARDs. Deze letters staan voor Disease-Modifying AntiRheumatic Drugs wat ‘ziekteverloop beïnvloedende geneesmiddelen tegen reuma’ betekent. - Bewegenzonderpijn.com
by Stieneke Hulshof - Artsen schrijven vaak medicijnen voor bij artritis om de symptomen en de voortschrijding van de ziekte in bedwang te houden. Er zijn verschillende categorieën van medicatie bij artritis: NSAIDs (niet-steroïde anti-inflammatoire drugs), analgetica (pijnstillers), DMARDs (ziekteverloop beïnvloedende geneesmiddelen tegen reuma), biologische middelen, en corticosteroïden. - Artroseblog.nl
by Stieneke Hulshof - psoriatische artritis (ontsteking van de gewrichten die geassocieerd wordt met psoriasis) wanneer
ziekteverloop beïnvloedende geneesmiddelen tegen reuma (‘disease-modifying anti-rheumatic
drugs’ – DMARD’s) niet goed genoeg werken;
- Ema.Europa.eu
by Stieneke Hulshof - Related KudoZ question
Compare [close] - Turkish
- Search
- Term
- hastalık modifiye edici antiromatizmal ilaçlar (DMARD)
- Additional fields of expertise
- Definition(s)
- Romatoid artrit, psöriyatik artrit ve ankilozan spondilit gibi eklem iltihabı ile seyreden hastalıkların tedavisinde kullanılan; sıradan anti-inflamatuvar ve ağrı kesici ilaçların aksine etkileri daha yavaş ortaya çıkan, fakat inflamasyon sürecinin temel evrelerinde rol oynayarak eklem erozyonunu geciktirebilen ve bu sayede hastalığın seyrini değiştiren ilaçlardır. Tıbbi literatürde hemen daima "hastalık modifiye edici ilaçlar" olarak adlandırılırlar. Own research - by FATİH ORUÇ
- Example sentence(s)
- Mevcut farmakolojik tedavi seçenekleri geleneksel sentetik hastalık modifiye edici antiromatizmal ilaçlar (csDMARD’lar), biyolojik DMARD’lar (bDMARD’lar) ve en yeni ilave olarak hedefe yönelik
sentetik DMARD’ları (tsDMARD’lar) içermektedir. - Sağlık Bakanlığı
by FATİH ORUÇ - 2010 kriterlerine göre, elde edilen veriler metotreksat (MTX) grubu için 0.804 duyarlılık (%95 güven aralığı [GA]; dağılım 0.737-0.857) ve 0.556 özgüllük (%95 GA; dağılım 0.417- 0.687); hastalık modifiye edici antiromatizmal ilaç (DMARD) grubunda 0.706 duyarlılık (%95 GA; dağılım 0.585-0.803) ve 0.691 özgüllük (%95 GA; dağılım 0.583-0.782) ve uzman grubunda 0.901 duyarlılık (%95 GA; dağılım 0.856-0.933) ve 0.539 özgüllük (%95 GA; dağılım 0.429-0.645) gösterdi. - TLAR
by FATİH ORUÇ - DMARD ''Disease Modifying Anti-Rheumatic Drugs'' kelimelerinin kısaltmasıdır. Hastalığı modifiye eden anti-romatizmal ilaçlar demektir. Bu ilaçlar günümüzde RA yanında diğer inflamatuar hastalıklarda da yaygın olarak kullanılmaktadırlar. Bu ilaçlara DMARD yanında yavaş etkili ilaçlar, remisyon sağlayıcı ilaçlar, uzun etkili ilaçlar, temel tedavi ilaçları veya temel etkili ilaçlar da denmektedir. - turkiyeklinikleri
by FATİH ORUÇ - Related KudoZ question
- Compare this term in: Bulgarian, German, Greek, Spanish, Persian (Farsi), French, Indonesian, Italian, Korean, Polish, Portuguese, Romanian, Ukrainian
| | The glossary compiled from Glossary-building KudoZ is made available openly under the Creative Commons "By" license (v3.0). By submitting this form, you agree to make your contribution available to others under the terms of that license. ![Creative Commons License](http://i.creativecommons.org/l/by/3.0/88x31.png) | | | | X Sign in to your ProZ.com account... | | | | | | |